Bortezomib is a proteasome inhibitor used in the treatment of multiple myeloma and other non-solid malignancies, alone or in combination with other chemotherapy drugs. Like other chemotherapeutic agents, bortezomib treatment is frequently accompanied by chemotherapy-induced peripheral neuropathy (CIPN) that may be dose-limiting, adversely affecting quality of life and prognosis. The mechanisms behind bortezomib-induced peripheral neuropathy (BIPN) and CIPN overall are largely unknown. Recent findings in other pain models have indicated substantial involvement of glial cells in chronic pain. Although injury models have shown activation of both astrocytes and microglia following insult, research in other CIPN models has shown astrocytic activ...
Background: Neuropathy is a dose-limiting side effect of many chemotherapeutics, including bortezomi...
Abstract Background Neuropathy is a dose-limiting side effect of many chemotherapeutics, including b...
Peripheral neuropathies, as the result of nerve damage, are characterized by pain, numbness, and tin...
Bortezomib is a proteasome inhibitor used in the treatment of multiple myeloma and other non-solid m...
The proteasome inhibitor bortezomib (BTZ) is a first-line antitumor drug, mainly used for multiple m...
Bortezomib is the first proteasome inhibitor with significant antineoplastic activity for the treatm...
Bortezomib is the first proteasome inhibitor with significant antineoplastic activity for the treatm...
The proteasome inhibitor bortezomib (BTZ) is a potent first-line anticancer drug for multiple myelom...
Bortezomib is the first proteasome inhibitor with significant antineoplastic activity for the treatm...
The proteasome inhibitor bortezomib (BTZ) is a potent first-line anticancer drug for multiple myelom...
Background: Neuropathy is a dose-limiting side effect of many chemotherapeutics, including bortezomi...
AbstractBortezomib, an effective anticancer drug for multiple myeloma, often causes peripheral neuro...
Bortezomib (BTZ), a selective ubiquitin-proteasome system inhibitor, is a potent antineoplastic drug...
Bortezomib (BTZ), a selective ubiquitin-proteasome system inhibitor, is a potent antineoplastic drug...
AbstractBortezomib, an effective anticancer drug for multiple myeloma, often causes peripheral neuro...
Background: Neuropathy is a dose-limiting side effect of many chemotherapeutics, including bortezomi...
Abstract Background Neuropathy is a dose-limiting side effect of many chemotherapeutics, including b...
Peripheral neuropathies, as the result of nerve damage, are characterized by pain, numbness, and tin...
Bortezomib is a proteasome inhibitor used in the treatment of multiple myeloma and other non-solid m...
The proteasome inhibitor bortezomib (BTZ) is a first-line antitumor drug, mainly used for multiple m...
Bortezomib is the first proteasome inhibitor with significant antineoplastic activity for the treatm...
Bortezomib is the first proteasome inhibitor with significant antineoplastic activity for the treatm...
The proteasome inhibitor bortezomib (BTZ) is a potent first-line anticancer drug for multiple myelom...
Bortezomib is the first proteasome inhibitor with significant antineoplastic activity for the treatm...
The proteasome inhibitor bortezomib (BTZ) is a potent first-line anticancer drug for multiple myelom...
Background: Neuropathy is a dose-limiting side effect of many chemotherapeutics, including bortezomi...
AbstractBortezomib, an effective anticancer drug for multiple myeloma, often causes peripheral neuro...
Bortezomib (BTZ), a selective ubiquitin-proteasome system inhibitor, is a potent antineoplastic drug...
Bortezomib (BTZ), a selective ubiquitin-proteasome system inhibitor, is a potent antineoplastic drug...
AbstractBortezomib, an effective anticancer drug for multiple myeloma, often causes peripheral neuro...
Background: Neuropathy is a dose-limiting side effect of many chemotherapeutics, including bortezomi...
Abstract Background Neuropathy is a dose-limiting side effect of many chemotherapeutics, including b...
Peripheral neuropathies, as the result of nerve damage, are characterized by pain, numbness, and tin...